MEMANTINE AND DONEPEZIL HYDROCHLORIDES
Drug Details
- Generic Name
- MEMANTINE AND DONEPEZIL HYDROCHLORIDES
- Brand Names
- MEMANTINE AND DONEPEZIL HYDROCHLORIDES
- Application Number
- ANDA208237
- Sponsor
- ANI Pharmaceuticals, Inc.
- NDC Codes
- 1
- Dosage Forms
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- DONEPEZIL HYDROCHLORIDE, MEMANTINE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Memantine and donepezil hydrochlorides extended-release capsules are indicated for the treatment of moderate to severe dementia of the Alzheimer's type in patients stabilized on 10 mg of donepezil hydrochloride once daily. Memantine and donepezil hydrochlorides extended-release capsules are a combination of memantine hydrochloride, an NMDA receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor, indicated for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on 10 mg of donepezil hydrochloride once daily. ( 1 )